119 related articles for article (PubMed ID: 38579578)
1. Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome.
Çelik Eroğlu B; Karaçoban L; Idılman IS; Korkusuz F; Yıldız BO
Maturitas; 2024 Jul; 185():107982. PubMed ID: 38579578
[TBL] [Abstract][Full Text] [Related]
2. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
3. Is muscle mechanical function altered in polycystic ovary syndrome?
Caliskan Guzelce E; Eyupoglu D; Torgutalp S; Aktoz F; Portakal O; Demirel H; Yildiz BO
Arch Gynecol Obstet; 2019 Sep; 300(3):771-776. PubMed ID: 31263987
[TBL] [Abstract][Full Text] [Related]
4. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
Ezeh U; Pall M; Mathur R; Azziz R
Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
[TBL] [Abstract][Full Text] [Related]
5. Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome.
Oguz SH; İdilman I; Helvaci N; Guzelce EC; Eyupoglu D; Karcaaltincaba M; Yildiz BO
Reprod Biomed Online; 2020 Aug; 41(2):329-334. PubMed ID: 32576491
[TBL] [Abstract][Full Text] [Related]
6. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS).
Barrea L; Arnone A; Annunziata G; Muscogiuri G; Laudisio D; Salzano C; Pugliese G; Colao A; Savastano S
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547562
[TBL] [Abstract][Full Text] [Related]
7. Correlates of increased lean muscle mass in women with polycystic ovary syndrome.
Carmina E; Guastella E; Longo RA; Rini GB; Lobo RA
Eur J Endocrinol; 2009 Oct; 161(4):583-9. PubMed ID: 19605540
[TBL] [Abstract][Full Text] [Related]
8. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
[TBL] [Abstract][Full Text] [Related]
9. Women With Polycystic Ovary Syndrome Have Comparable Hip Bone Geometry to Age-Matched Control Women.
McBreairty LE; Zello GA; Gordon JJ; Serrao SB; Pierson RA; Chizen DR; Chilibeck PD
J Clin Densitom; 2018; 21(1):54-60. PubMed ID: 28034591
[TBL] [Abstract][Full Text] [Related]
10. Women with polycystic ovary syndrome have greater muscle strength irrespective of body composition.
Kogure GS; Silva RC; Picchi Ramos FK; Miranda-Furtado CL; Lara LA; Ferriani RA; Dos Reis RM
Gynecol Endocrinol; 2015 Mar; 31(3):237-42. PubMed ID: 25430509
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic Fatty Liver Disease, Bone and Muscle Quality in Prolactinoma: A Pilot Study.
Eroğlu İ; Iremli BG; Erkoc A; Idilman IS; Yuce D; Kutukcu EC; Akata D; Erbas T
J Clin Densitom; 2024; 27(2):101479. PubMed ID: 38447349
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study.
McBreairty LE; Chilibeck PD; Gordon JJ; Chizen DR; Zello GA
BMC Endocr Disord; 2019 Jul; 19(1):70. PubMed ID: 31262307
[TBL] [Abstract][Full Text] [Related]
13. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
14. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance.
Mario FM; do Amarante F; Toscani MK; Spritzer PM
Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):511-6. PubMed ID: 22576259
[TBL] [Abstract][Full Text] [Related]
15. Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study.
Kazemi M; Jarrett BY; Parry SA; Thalacker-Mercer AE; Hoeger KM; Spandorfer SD; Lujan ME
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3400-14. PubMed ID: 32614948
[TBL] [Abstract][Full Text] [Related]
16. Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients.
Karadağ C; Yoldemir T; Gogas Yavuz D
Gynecol Endocrinol; 2017 Mar; 33(3):234-237. PubMed ID: 27908213
[TBL] [Abstract][Full Text] [Related]
17. Obesity and Insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women.
Pereira-Eshraghi CF; Chiuzan C; Zhang Y; Tao RH; McCann M; Neugut YD; Printz A; Fennoy I; Cree-Green M; Oberfield SE; Sopher AB
Horm Res Paediatr; 2019; 92(6):365-371. PubMed ID: 32348991
[TBL] [Abstract][Full Text] [Related]
18. Physical Performance Regarding Handgrip Strength in Women with Polycystic Ovary Syndrome.
Kogure GS; Ribeiro VB; Gennaro FGO; Ferriani RA; Miranda-Furtado CL; Reis RMD
Rev Bras Ginecol Obstet; 2020 Dec; 42(12):811-819. PubMed ID: 33348398
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
20. Hyperandrogenism Enhances Muscle Strength After Progressive Resistance Training, Independent of Body Composition, in Women With Polycystic Ovary Syndrome.
Kogure GS; Silva RC; Miranda-Furtado CL; Ribeiro VB; Pedroso DCC; Melo AS; Ferriani RA; Reis RMD
J Strength Cond Res; 2018 Sep; 32(9):2642-2651. PubMed ID: 29927897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
